MedPath

PHL-NIZATIDINE

PHL-NIZATIDINE

Discontinued
DIN Number

02238195

Drug Class

Human

Market Date

Mar 1, 1999

Company
HC

pharmel inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02238195
AIG Number0120317002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A02BA04 NIZATIDINE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:28.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

NIZATIDINEActive
Strength: 300 MG
Monograph: NIZATIDINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.